|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05.02.26 - 16:15
|
Cleveland Diagnostics Names Jack Kenny as Chairman of the Board (Business Wire)
|
|
|
Seasoned industry executive brings proven leadership to support commercial scale of IsoPSA® Assay & platform expansionCLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, today announced the appointment of Jack Kenny as Chairman of the Board of Directors. Kenny joins the company at a pivotal time as Cleveland Diagnostics accelerates commercial growth following recent FDA approval of its IsoPSA® IVD Assay and expands its broader IsoClear™ platform.
Kenny brings more than three decades of operational, commercial, and board-level leadership experience across the diagnostics and life sciences industries. He has deep expertise in the in vitro diagnostics, molecular, and laboratory services sectors. Most recently, he served as Chief Executive Officer of Meridian Bioscience. His prior leadership roles include senior executive positions at Siemens Healthcare, Becton Dickinson Diagnostics, Danaher, and Quest Diagnostics, as well as current and past...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.01.26 - 22:18
|
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 (PR Newswire)
|
|
|
FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common share, payable on March 31, 2026, to holders......
|
|
|
|
|
|
|
|
|
|